Stanley Cohen (biochemist)

Stanley Cohen (biochemist)
source
Name	Stanley Cohen
Birth date	1922-11-17
Birth place	Brooklyn, New York
Death date	2020-02-05
Death place	Nashville, Tennessee
Nationality	United States
Field	Biochemistry, Cell Biology
Alma mater	Brooklyn College; University of Michigan
Known for	Discovery of epidermal growth factor; studies of growth factors
Awards	Nobel Prize in Physiology or Medicine (1986)

Stanley Cohen (biochemist) was an American biochemist and cell biologist whose work on peptide growth factors transformed molecular biology, oncology, and developmental biology. His collaborations with physicians, geneticists, and pharmacologists led to foundational advances linking proteins to cell proliferation, influencing research at institutions such as Vanderbilt University, National Institutes of Health, and laboratories associated with the Rockefeller University and Harvard Medical School. Cohen's findings intersected with work by contemporaries at the University of California, Berkeley, Cold Spring Harbor Laboratory, and industrial research programs at Merck and Pfizer.

Early life and education

Cohen was born in Brooklyn and attended James Madison High School (Brooklyn), before enrolling at Brooklyn College where he studied chemistry alongside students influenced by faculty from Columbia University and the City College of New York. He pursued graduate training at the University of Michigan in Ann Arbor, Michigan, working under advisors connected to researchers at Rockefeller University and collaborators from Johns Hopkins University School of Medicine. During World War II-era scientific mobilization, Cohen's education intersected with programs sponsored by agencies such as the Office of Scientific Research and Development and laboratories linked to Rutgers University and the University of Chicago.

Research and scientific career

Cohen joined the faculty at Vanderbilt University where he established a biochemical laboratory that collaborated with clinicians from the Veterans Affairs Medical Center and investigators from Washington University in St. Louis. His wartime and postwar contemporaries included scientists from Massachusetts Institute of Technology, University of California, San Francisco, and Stanford University, fostering interdisciplinary studies in enzymology, hormone biochemistry, and protein chemistry. He worked closely with pathologists and pediatricians connected to Cornell University and with molecular biologists whose work linked to laboratories at Yale University and Princeton University. Cohen's laboratory employed techniques developed at Cold Spring Harbor Laboratory and methodologies influenced by protocols from the American Association for the Advancement of Science community.

Major discoveries and contributions

Cohen is best known for the isolation and characterization of epidermal growth factor (EGF) and elucidation of its receptor-mediated action, a discovery that linked extracellular peptides to intracellular signaling pathways studied at centers such as Max Planck Society-affiliated institutes and the Salk Institute. His work complemented discoveries by researchers at Columbia University and the National Cancer Institute regarding oncogenes and receptor tyrosine kinases, and it informed therapeutic strategies developed at Genentech and biotechnology programs in Cambridge, Massachusetts. The identification of EGF influenced research on cell cycle control pursued at Cold Spring Harbor Laboratory and mechanistic studies by teams at Harvard Medical School and University of California, San Diego. Cohen's findings intersected with the discoveries of viral oncogenes at Sloan Kettering Institute and genetic regulation work performed at University College London and the Weizmann Institute of Science. His biochemical purification of growth factors and demonstration of receptor binding helped pave the way for targeted therapies used in oncology divisions at institutions like Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center.

Awards and honors

Cohen received numerous honors recognizing his impact on biomedical science, including the Nobel Prize in Physiology or Medicine, awarded in a ceremony attended by representatives from the Royal Swedish Academy of Sciences, and acknowledgments from organizations such as the National Academy of Sciences and the American Academy of Arts and Sciences. He held honorary degrees and fellowships linked to universities including Yale University, Princeton University, and University of Pennsylvania. Other awards came from societies tied to American Society for Biochemistry and Molecular Biology, Federation of American Societies for Experimental Biology, and international bodies connected to the European Molecular Biology Organization.

Personal life and legacy

Cohen married and raised a family in Nashville, Tennessee, where he maintained connections with clinical researchers at Vanderbilt University Medical Center and policy makers who engaged with the National Institutes of Health. His legacy is reflected in curricula at medical schools such as Columbia University Vagelos College of Physicians and Surgeons and research programs at institutes like the Broad Institute and the Whitehead Institute. Many of his trainees and collaborators went on to leadership positions at institutions including Stanford University School of Medicine, University of California, Los Angeles, University of Chicago, and Imperial College London, perpetuating research on growth factors, signal transduction, and targeted therapeutics. Cohen's work continues to be cited in literature from oncology centers such as Dana–Farber Cancer Institute and in translational projects undertaken by pharmaceutical companies including Amgen and AstraZeneca.

Category:1922 births Category:2020 deaths Category:American biochemists Category:Nobel laureates in Physiology or Medicine Category:Vanderbilt University faculty